Aligning the Economic Value of Companion Diagnostics and Stratified Medicines

The twin forces of payors seeking fair pricing and the rising costs of developing new medicines has driven a closer relationship between pharmaceutical companies and diagnostics companies, because stratified medicines, guided by companion diagnostics, offer better commercial, as well as clinical, ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Edward D., Stratton, Elyse K., Kaufmann, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251370/
https://www.ncbi.nlm.nih.gov/pubmed/25562363
http://dx.doi.org/10.3390/jpm2040257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251370/
https://www.ncbi.nlm.nih.gov/pubmed/25562363
http://dx.doi.org/10.3390/jpm2040257

Ejemplares similares